2
RESEARCH METHODOLOGY
34
5
MARKET OVERVIEW
Telehealth growth driven by AI innovations, personalized care, and strategic partnerships amid regulatory challenges.
58
5.2.1.1
EXPANDING TELEHEALTH AND REMOTE PATIENT MONITORING MARKETS
5.2.1.2
INCREASING PREVALENCE OF CHRONIC DISEASES
5.2.1.3
FOCUS ON DEVELOPMENT AND ADOPTION OF MHEALTH APPLICATIONS
5.2.1.4
INCREASED GOVERNMENT SUPPORT AND FAVORABLE REIMBURSEMENT POLICIES
5.2.1.5
GROWING AWARENESS ABOUT LIFESTYLE MANAGEMENT AND HOME HEALTHCARE
5.2.2.1
REGULATORY VARIATIONS ACROSS REGIONS
5.2.2.2
SHORTAGE OF SKILLED PROFESSIONALS TO OPERATE AI-BASED REMOTE PATIENT MONITORING TOOLS
5.2.2.3
DATA SECURITY CONCERNS
5.2.3.1
GROWING DEMAND FOR PERSONALIZED MEDICINES AND CARE PLANS
5.2.3.2
INCREASE IN PARTNERSHIPS AND COLLABORATIONS AMONG HEALTHCARE PROVIDERS AND AI-BASED COMPANIES
5.2.3.3
GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
5.2.3.4
RISING INVESTMENT IN AI-BASED REMOTE PATIENT MONITORING SOLUTIONS
5.2.4.1
SCARCITY OF HIGH-QUALITY HEALTHCARE DATA AND PRIVACY CONCERNS
5.2.4.2
RELUCTANCE AMONG HEALTHCARE PROFESSIONALS TO ADOPT AI IN REMOTE PATIENT MONITORING DEVICES
5.2.4.3
LACK OF INTEROPERABILITY
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4.1
SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE
5.4.2
INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGIES
5.7.1.1
WEARABLE DEVICES AND SENSORS
5.7.1.3
PREDICTIVE ANALYTICS
5.7.2
COMPLEMENTARY TECHNOLOGIES
5.7.2.1
MHEALTH APPLICATIONS
5.7.2.3
DIGITAL HEALTH PLATFORMS
5.7.3
ADJACENT TECHNOLOGIES
5.7.3.1
POINT-OF-CARE DIAGNOSTICS
5.7.3.2
SMART HOME HEALTH DEVICES
5.8
TARIFF & REGULATORY ANALYSIS
5.8.1.1
TARIFF DATA FOR HS CODE 9018
5.8.1.2
TARIFF DATA FOR HS CODE 9021
5.8.1.3
TARIFF DATA FOR HS CODE 9022
5.8.2
REGULATORY FRAMEWORK
5.8.2.4
MIDDLE EAST & AFRICA
5.8.3
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.1
TRADE ANALYSIS FOR HSN CODE 90189099
5.9.1.1
IMPORT DATA FOR HSN CODE 90189099
5.9.1.2
EXPORT DATA FOR HSN CODE 90189099
5.9.2
TRADE ANALYSIS FOR HSN CODE 9021
5.9.2.1
IMPORT DATA FOR HSN CODE 9021
5.9.2.2
EXPORT DATA FOR HSN CODE 9021
5.9.3
TRADE ANALYSIS FOR HSN CODE 9022
5.9.3.1
IMPORT DATA FOR HSN CODE 9022
5.9.3.2
EXPORT DATA FOR HSN CODE 9022
5.10.1
INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023
5.10.2
INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023
5.11
PORTER’S FIVE FORCES ANALYSIS
5.11.1
INTENSITY OF COMPETITIVE RIVALRY
5.11.2
BARGAINING POWER OF BUYERS
5.11.3
THREAT OF SUBSTITUTES
5.11.4
THREAT OF NEW ENTRANTS
5.11.5
BARGAINING POWER OF SUPPLIERS
5.12
KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2
KEY BUYING CRITERIA
5.13.1
PATENT PUBLICATION TRENDS
5.13.2
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS
5.13.3
TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET
5.13.4
LIST OF KEY PATENTS/PATENT APPLICATIONS
5.14
UNMET NEEDS & END-USER EXPECTATIONS
5.14.2
END-USER EXPECTATIONS
5.15
KEY CONFERENCES & EVENTS, 2025–2026
5.16.1
ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING
5.16.2
ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS
5.16.3
ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY
5.17
INVESTMENT & FUNDING SCENARIO
5.18
BUSINESS MODEL ANALYSIS
5.18.1
SUBSCRIPTION-BASED MODELS
5.18.2
PLATFORM-AS-A-SERVICE MODELS
5.18.3
SERVICE-BASED MODELS
5.18.5
COLLABORATIVE ECOSYSTEM AND PARTNERSHIP MODELS
5.19
REIMBURSEMENT SCENARIO ANALYSIS
6
AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 10 Data Tables
111
6.2.1.1
RISING ADOPTION OF CONSUMER HEALTH TECHNOLOGIES AND GROWING TREND TOWARD PREVENTIVE HEALTHCARE TO DRIVE SEGMENT
6.2.2
IMPLANTABLE DEVICES
6.2.2.1
DEVELOPMENT OF WIRELESS COMMUNICATION TECHNOLOGIES AND ADVANCEMENTS IN MEDICAL DEVICES TO SPUR MARKET ADOPTION
6.2.3
HANDHELD & PORTABLE DEVICES
6.2.3.1
RISING CONSUMER PREFERENCE FOR HOME HEALTHCARE AND SELF-MONITORING TO AID MARKET GROWTH
6.2.4.1
REDUCED HOSPITALIZATIONS AND IMPROVED PATIENT OUTCOMES THROUGH TIMELY ALERTS TO AID MARKET GROWTH
6.3.1
EFFECTIVE TRANSFORMATION OF RAW DATA TO PERSONALIZED INSIGHTS FOR PATIENTS TO AUGMENT MARKET GROWTH
6.4.1
INCREASING NEED FOR VALUE-BASED SPECIALIZED SERVICES TO BOOST MARKET GROWTH
7
AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
121
7.2.1
NEED FOR IMPROVED SYMPTOM MONITORING AND PERSONALIZED TREATMENT PLANS TO DRIVE MARKET
7.3.1
INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH
7.4.1
GROWING ADOPTION OF TELEMEDICINE AND RISING NEED FOR CONTINUOUS MONITORING TO AID MARKET GROWTH
7.5.1
HIGH ADOPTION OF AI-POWERED DEVICES FOR EFFECTIVE DIABETES MANAGEMENT TO PROPEL MARKET GROWTH
7.6.1
AI-POWERED REMOTE PATIENT MONITORING DEVICES TO ENSURE EFFECTIVE SLEEP APNEA MANAGEMENT
7.7.1
GROWING BURDEN OF COPD AND ASTHMA IN LOW- AND MIDDLE-INCOME COUNTRIES TO SUPPORT MARKET GROWTH
7.8.1
RISING PREVALENCE OF OBESITY AND LIFESTYLE DISEASES TO AUGMENT MARKET GROWTH
7.9
MENTAL HEALTH DISORDERS
7.9.1
AI-BASED REMOTE PATIENT MONITORING TO IMPROVE ACCESS TO MENTAL HEALTH SUPPORT AND REDUCE STIGMA OF IN-PERSON THERAPY
8
AI IN REMOTE PATIENT MONITORING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 13 Data Tables
131
8.2.1.1
RISING DEMAND FOR HIGH-QUALITY CARE AND INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
8.2.2
AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
8.2.2.1
AI-DRIVEN REMOTE PATIENT MONITORING DEVICES TO ENHANCE POSTOPERATIVE CARE, PATIENT SAFETY, AND RECOVERY OUTCOMES
8.2.3
LONG-TERM CARE & ASSISTED LIVING FACILITIES
8.2.3.1
NEED FOR PROLONGED TREATMENT FOR CHRONIC DISEASES AND HIGH COST OF HOSPITAL STAYS TO FUEL UPTAKE
8.2.4
HOME HEALTHCARE FACILITIES
8.2.4.1
INCREASED PREFERENCE FOR AT-HOME TREATMENT OPTIONS TO DRIVE MARKET
8.2.5
OTHER HEALTHCARE PROVIDERS
8.3.1
FAVORABLE REIMBURSEMENT SCENARIO FOR REMOTE PATIENT MONITORING SERVICES TO AUGMENT MARKET GROWTH
8.4.1
ADVANCEMENTS IN WEARABLE DEVICES AND PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH
8.5
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.5.1
AI-BASED REMOTE PATIENT MONITORING SOLUTIONS TO ASSIST PHARMA COMPANIES EXPAND MARKET PRESENCE
8.6.1
RISING DEMAND FOR ADVANCED TECHNOLOGIES FOR REMOTE DISEASE DIAGNOSIS AND TREATMENT TO FAVOR MARKET GROWTH
9
AI IN REMOTE PATIENT MONITORING MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 12 Countries | 116 Data Tables.
142
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2.1
US TO DOMINATE NORTH AMERICAN MARKET DURING STUDY PERIOD
9.2.3.1
NEED TO CURTAIL HEALTHCARE COSTS AND HIGH PENETRATION OF SMARTPHONES AND TABLETS TO DRIVE MARKET
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2.1
HIGH HEALTHCARE EXPENDITURE AND INCREASED PREFERENCE FOR HOME MONITORING TO PROPEL MARKET GROWTH
9.3.3.1
FAVORABLE GOVERNMENT INITIATIVES AND HIGH DEMAND FOR ADVANCED HEALTHCARE SOLUTIONS TO AID MARKET GROWTH
9.3.4.1
INCREASED ADOPTION OF CONNECTED MEDICAL DEVICES TO FUEL MARKET GROWTH
9.3.5.1
INCREASED GOVERNMENT HEALTH EXPENDITURE AND HIGH GERIATRIC POPULATION TO BOOST MARKET GROWTH
9.3.6.1
NEED TO REDUCE HEALTHCARE COSTS AND IMPROVE TREATMENT QUALITY TO DRIVE ADOPTION OF AI-BASED REMOTE PATIENT MONITORING DEVICES
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2.1
STRONG INTERNET ACCESS AND HIGH SMARTPHONE ADOPTION TO AUGMENT MARKET GROWTH
9.4.3.1
RISING GERIATRIC POPULATION AND INCREASING GOVERNMENT HEALTH EXPENDITURE TO AID MARKET GROWTH
9.4.4.1
NEED TO BRIDGE GAP BETWEEN RURAL PATIENTS AND URBAN DOCTORS TO PROPEL MARKET GROWTH
9.4.5
REST OF ASIA PACIFIC
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2.1
FAVORABLE GOVERNMENT INITIATIVES AND INCREASED HEALTH EXPENDITURE TO FAVOR MARKET GROWTH
9.5.3.1
TECHNOLOGICAL ADVANCEMENTS AND FAVORABLE LEGAL POLICIES FOR DIGITAL HEALTH TECHNOLOGIES TO DRIVE MARKET
9.5.4
REST OF LATIN AMERICA
9.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2.1
FAVORABLE GOVERNMENT AND NON-GOVERNMENT INITIATIVES AND INCREASED INVESTMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
9.6.3
REST OF MIDDLE EAST & AFRICA
10
COMPETITIVE LANDSCAPE
Uncover key players' winning strategies and market dominance in AI-driven remote patient monitoring.
213
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS FOR AI IN REMOTE PATIENT MONITORING MARKET
10.3
REVENUE ANALYSIS, 2019–2023
10.4
MARKET SHARE ANALYSIS, 2023
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1
COMPANY FOOTPRINT
10.5.5.2
REGION FOOTPRINT
10.5.5.3
COMPONENT FOOTPRINT
10.5.5.4
INDICATION FOOTPRINT
10.5.5.5
END-USER FOOTPRINT
10.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
10.6.1
PROGRESSIVE COMPANIES
10.6.2
RESPONSIVE COMPANIES
10.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
10.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
10.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
10.7
COMPANY VALUATION & FINANCIAL METRICS
10.8
BRAND/SOFTWARE COMPARISON
10.9
COMPETITIVE SCENARIO
10.9.1
PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
10.9.4
OTHER DEVELOPMENTS
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
235
11.1.1.1
BUSINESS OVERVIEW
11.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
11.1.1.3
RECENT DEVELOPMENTS
11.1.2
KONINKLIJKE PHILIPS N.V.
11.1.4
BOSTON SCIENTIFIC CORPORATION
11.1.5
OMRON HEALTHCARE, INC.
11.1.7
NIHON KOHDEN CORPORATION
11.1.8
F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS)
11.1.10
BEIJING CHOICE ELECTRONIC TECH CO., LTD.
11.1.20
TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE)
11.2.1
BIOINTELLISENSE, INC.
11.2.2
BLUE SPARK TECHNOLOGIES, INC.
11.2.4
AION BIOSYSTEMS, INC.
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3
CUSTOMIZATION OPTIONS
TABLE 1
AI IN REMOTE PATIENT MONITORING MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3
AI IN REMOTE PATIENT MONITORING MARKET: FACTOR ANALYSIS
TABLE 4
AI IN REMOTE PATIENT MONITORING MARKET: MARKET SIZING ASSUMPTIONS
TABLE 5
AI IN REMOTE PATIENT MONITORING MARKET: RISK ASSESSMENT
TABLE 6
AI IN REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 7
RECENT DEVELOPMENTS IN AI-BASED SOLUTIONS FOR REMOTE PATIENT MONITORING, JANUARY 2022–DECEMBER 2024
TABLE 8
AI IN REMOTE PATIENT MONITORING MARKET: ROLE IN ECOSYSTEM
TABLE 9
AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9018
TABLE 10
AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9021
TABLE 11
AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9022
TABLE 12
REGULATORY SCENARIO OF NORTH AMERICA
TABLE 13
REGULATORY SCENARIO OF EUROPE
TABLE 14
REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 15
REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 16
REGULATORY SCENARIO OF LATIN AMERICA
TABLE 17
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 23
TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 24
TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 25
TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 26
TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 27
TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 28
INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023
TABLE 29
INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023
TABLE 30
AI IN REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES
TABLE 31
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 32
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 33
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS
TABLE 34
AI IN REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS
TABLE 35
AI IN REMOTE PATIENT MONITORING MARKET: UNMET NEEDS
TABLE 36
AI IN REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS
TABLE 37
AI IN REMOTE PATIENT MONITORING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 38
CASE STUDY 1: ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING
TABLE 39
CASE STUDY 2: ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS
TABLE 40
CASE STUDY 2: ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY
TABLE 41
CPT CODES AND REIMBURSEMENT ANALYSIS FOR AI-BASED REMOTE PATIENT MONITORING DEVICES IN US
TABLE 42
AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 43
AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 44
AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 45
AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (THOUSAND UNITS)
TABLE 46
AI IN REMOTE PATIENT MONITORING WEARABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 47
AI IN REMOTE PATIENT MONITORING IMPLANTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 48
AI IN REMOTE PATIENT MONITORING HANDHELD & PORTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 49
AI IN REMOTE PATIENT MONITORING STATIONARY DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 50
AI IN REMOTE PATIENT MONITORING SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 51
AI IN REMOTE PATIENT MONITORING SERVICES MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 52
AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 53
AI IN REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2022–2030 (USD MILLION)
TABLE 54
AI IN REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2022–2030 (USD MILLION)
TABLE 55
AI IN REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2022–2030 (USD MILLION)
TABLE 56
AI IN REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2022–2030 (USD MILLION)
TABLE 57
AI IN REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 58
AI IN REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022–2030 (USD MILLION)
TABLE 59
AI IN REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT, BY REGION, 2022–2030 (USD MILLION)
TABLE 60
AI IN REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 61
AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2022–2030 (USD MILLION)
TABLE 62
AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 63
AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 64
AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 65
AI IN REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
TABLE 66
AI IN REMOTE PATIENT MONITORING MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION)
TABLE 67
AI IN REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION)
TABLE 68
AI IN REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE FACILITIES, BY REGION, 2022–2030 (USD MILLION)
TABLE 69
AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 70
AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 71
AI IN REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION)
TABLE 72
AI IN REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION)
TABLE 73
AI IN REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)
TABLE 74
AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
TABLE 75
AI IN REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 76
NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 77
NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 78
NORTH AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 79
NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 80
NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 81
NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 82
US: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 83
US: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 84
US: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 85
US: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 86
US: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 87
CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 88
CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 89
CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 90
CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 91
CANADA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 92
EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 93
EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 94
EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 95
EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 96
EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 97
EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 98
GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 99
GERMANY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 100
GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 101
GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 102
GERMANY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 103
UK: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 104
UK: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 105
UK: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 106
UK: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 107
UK: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 108
FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 109
FRANCE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 110
FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 111
FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 112
FRANCE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 113
ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 114
ITALY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 115
ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 116
ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 117
ITALY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 118
SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 119
SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 120
SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 121
SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 122
SPAIN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 123
REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 124
REST OF EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 125
REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 126
REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 127
REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 128
ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 129
ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 130
ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 131
ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 132
ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 133
ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 134
CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 135
CHINA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 136
CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 137
CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 138
CHINA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 139
JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 140
JAPAN: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 141
JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 142
JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 143
JAPAN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 144
INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 145
INDIA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 146
INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 147
INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 148
INDIA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 149
REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 150
REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 151
REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 152
REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 153
REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 154
LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
TABLE 155
LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 156
LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 157
LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 158
LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 159
LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 160
BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 161
BRAZIL: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 162
BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 163
BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 164
BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 165
MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 166
MEXICO: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 167
MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 168
MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 169
MEXICO: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 170
REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 171
REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 172
REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 173
REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 174
REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 175
MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)
TABLE 176
MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 177
MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 178
MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 179
MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 180
MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 181
GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 182
GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 183
GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 184
GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 185
GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 186
REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)
TABLE 187
REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)
TABLE 188
REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)
TABLE 189
REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)
TABLE 190
REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)
TABLE 191
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021–JANUARY 2025
TABLE 192
AI IN REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION
TABLE 193
AI IN REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT
TABLE 194
AI IN REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT
TABLE 195
AI IN REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT
TABLE 196
AI IN REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT
TABLE 197
AI IN REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 198
AI IN REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 199
AI IN REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021–JANUARY 2025
TABLE 200
AI IN REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021–JANUARY 2025
TABLE 201
AI IN REMOTE PATIENT MONITORING MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025
TABLE 202
AI IN REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 203
MEDTRONIC: COMPANY OVERVIEW
TABLE 204
MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 205
MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 206
MEDTRONIC: DEALS, JANUARY 2021–JANUARY 2025
TABLE 207
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 208
KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 209
KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 210
KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 211
GE HEALTHCARE: COMPANY OVERVIEW
TABLE 212
GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 213
GE HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025
TABLE 214
BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 215
BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 216
BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
TABLE 217
BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–JANUARY 2025
TABLE 218
BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021–JANUARY 2025
TABLE 219
BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 220
OMRON HEALTHCARE, INC.: COMPANY OVERVIEW
TABLE 221
OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 222
OMRON HEALTHCARE, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
TABLE 223
OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 224
RESMED, INC.: COMPANY OVERVIEW
TABLE 225
RESMED, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 226
RESMED, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
TABLE 227
RESMED, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 228
RESMED, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025
TABLE 229
RESMED, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 230
NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
TABLE 231
NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 232
NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 233
NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–JANUARY 2025
TABLE 234
NIHON KOHDEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 235
F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY OVERVIEW
TABLE 236
F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 237
F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 238
F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): DEALS, JANUARY 2021–JANUARY 2025
TABLE 239
IRHYTHM INC.: COMPANY OVERVIEW
TABLE 240
IRHYTHM INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 241
IRHYTHM INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 242
IRHYTHM INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 243
BEIJING CHOICE ELECTRONIC TECH CO., LTD.: COMPANY OVERVIEW
TABLE 244
BEIJING CHOICE ELECTRONIC TECH CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 245
BIOTRONIK: COMPANY OVERVIEW
TABLE 246
BIOTRONIK: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 247
BIOTRONIK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 248
BIOTRONIK: DEALS, JANUARY 2021–JANUARY 2025
TABLE 249
ALIVECOR, INC.: COMPANY OVERVIEW
TABLE 250
ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 251
ALIVECOR, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 252
ALIVECOR, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 253
ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 254
MASIMO: COMPANY OVERVIEW
TABLE 255
MASIMO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 256
MASIMO: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
TABLE 257
MASIMO: DEALS, JANUARY 2021–JANUARY 2025
TABLE 258
DEXCOM, INC.: COMPANY OVERVIEW
TABLE 259
DEXCOM, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 260
DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 261
DEXCOM, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 262
BIOBEAT: COMPANY OVERVIEW
TABLE 263
BIOBEAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 264
BIOBEAT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 265
BIOBEAT: DEALS, JANUARY 2021–JANUARY 2025
TABLE 266
TYTOCARE LTD.: COMPANY OVERVIEW
TABLE 267
TYTOCARE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 268
TYTOCARE LTD.: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025
TABLE 269
TYTOCARE LTD.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 270
TYTOCARE LTD.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 271
ZETO INC.: COMPANY OVERVIEW
TABLE 272
ZETO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 273
GLOOKO, INC.: COMPANY OVERVIEW
TABLE 274
GLOOKO, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 275
GLOOKO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
TABLE 276
GLOOKO, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 277
GLOOKO, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 278
WELLDOC, INC.: COMPANY OVERVIEW
TABLE 279
WELLDOC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 280
WELLDOC, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021–JANUARY 2025
TABLE 281
WELLDOC, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 282
TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): COMPANY OVERVIEW
TABLE 283
TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCTS/SERVICES/ SOLUTIONS OFFERED
TABLE 284
TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 285
TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 286
BIOINTELLISENSE, INC.: COMPANY OVERVIEW
TABLE 287
BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 288
ACCURKARDIA, INC.: COMPANY OVERVIEW
TABLE 289
AION BIOSYSTEMS, INC.: COMPANY OVERVIEW
TABLE 290
BROOK INC.: COMPANY OVERVIEW
FIGURE 1
AI IN REMOTE PATIENT MONITORING MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
FIGURE 2
AI IN REMOTE PATIENT MONITORING MARKET: YEARS CONSIDERED
FIGURE 3
AI IN REMOTE PATIENT MONITORING MARKET: RESEARCH DESIGN
FIGURE 4
AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
AI IN REMOTE PATIENT MONITORING MARKET: KEY PRIMARY SOURCES
FIGURE 6
AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 7
AI IN REMOTE PATIENT MONITORING MARKET: INSIGHTS FROM PRIMARIES
FIGURE 8
BREAKDOWN OF PRIMARY SOURCES: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 9
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 10
AI IN REMOTE PATIENT MONITORING MARKET: SUPPLY-SIDE MARKET ESTIMATION
FIGURE 11
AI IN REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH FOR OMRON HEALTHCARE, INC. (2023)
FIGURE 12
BOTTOM-UP APPROACH: END-USER SPENDING ON AI-BASED REMOTE PATIENT MONITORING SOLUTIONS
FIGURE 13
AI IN REMOTE PATIENT MONITORING MARKET: TOP-DOWN APPROACH
FIGURE 14
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)
FIGURE 15
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 16
AI IN REMOTE PATIENT MONITORING MARKET: DATA TRIANGULATION
FIGURE 17
AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
FIGURE 18
AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION)
FIGURE 19
AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
FIGURE 20
AI IN REMOTE PATIENT MONITORING MARKET: REGIONAL SNAPSHOT
FIGURE 21
IMPROVED MEDICAL INFRASTRUCTURE AND COST BENEFITS OF REMOTE HEALTH MONITORING TO DRIVE MARKET
FIGURE 22
US AND HEALTHCARE PROVIDERS TO COMMAND LARGEST NORTH AMERICAN MARKET SHARE IN 2023
FIGURE 23
INDIA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
FIGURE 24
EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
FIGURE 25
AI IN REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 26
US MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024
FIGURE 27
AI IN REMOTE PATIENT MONITORING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 28
AI IN REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
FIGURE 29
AI IN REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
FIGURE 30
AVERAGE SELLING PRICE FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY TYPE (2023)
FIGURE 31
AI IN REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 32
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
FIGURE 33
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 34
PATENT PUBLICATION TRENDS IN AI IN REMOTE PATIENT MONITORING MARKET, 2015–2024
FIGURE 35
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS (JANUARY 2015–DECEMBER 2024)
FIGURE 36
TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015–DECEMBER 2024)
FIGURE 37
AI IN REMOTE PATIENT MONITORING MARKET: FUNDING AND NUMBER OF DEALS, 2022–2024
FIGURE 38
US: PERCENTAGE OF NEW CANCER CASES (2024)
FIGURE 39
NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT
FIGURE 40
ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT
FIGURE 41
REVENUE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, 2019–2023 (USD MILLION)
FIGURE 42
MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET (2023)
FIGURE 43
AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 44
AI IN REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT
FIGURE 45
AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 46
EV/EBITDA OF KEY VENDORS
FIGURE 47
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 48
AI IN REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
FIGURE 49
MEDTRONIC: COMPANY SNAPSHOT
FIGURE 50
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 51
GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 52
BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 53
OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT
FIGURE 54
RESMED, INC.: COMPANY SNAPSHOT
FIGURE 55
NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
FIGURE 56
F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY SNAPSHOT
FIGURE 57
IRHYTHM INC.: COMPANY SNAPSHOT
FIGURE 58
MASIMO: COMPANY SNAPSHOT
FIGURE 59
DEXCOM, INC.: COMPANY SNAPSHOT
Growth opportunities and latent adjacency in AI in Remote Patient Monitoring (RPM) Market